CollPlant Holdings - Big potential for BioInk
Over the course of H217, CollPlant announced that it had received orders for its BioInk product from two companies for development of 3D printed...
71 Views
CollPlant Holdings - Steady commercial advancement
CollPlant’s Q317 marked continued commercial progress and increasing interest in its plant-based recombinant human collagen (rhCollagen) based...
92 Views
Fund-raising should enable strategic delivery
CollPlant has announced the signing of a definitive agreement with a US investor for a $5m private placing. The investment is in three tranches:...
53 Views
Continuing to build on 2016
CollPlant is building on its progress in 2016 by increasing its distribution of VergenixFG and actively pursuing potential partnerships for its...
72 Views
Good progress in 2016
2016 was an important year for CollPlant as it completed a clinical study and received its CE approval for VergenixSTR, entered into an exclusive...
27 Views
No more insights